Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial
曲妥珠单抗联合三联疗法治疗HER2过表达食管腺癌(NRG Oncology/RTOG 1010):一项多中心、随机、3期试验
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(21)00718-X
Safran, Howard P; Winter, Kathryn; Ilson, David H; Wigle, Dennis; DiPetrillo, Thomas; Haddock, Michael G; Hong, Theodore S; Leichman, Lawrence P; Rajdev, Lakshmi; Resnick, Murray; Kachnic, Lisa A; Seaward, Samantha; Mamon, Harvey; Diaz Pardo, Dayssy Alexandra; Anderson, Carryn M; Shen, Xinglei; Sharma, Anand K; Katz, Alan W; Salo, Jonathan; Leonard, Kara L; Moughan, Jennifer; Crane, Christopher H